Skip to main content

Carlos Nos Llopis

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Carlos Nos Llopis

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Red Española de Esclerosis Múltiple (perteneciente a la Red CIEN C03/06): Desarrollo de marcadores biológicos y clínicos de la respuesta al tratamiento con Interferón beta en esclerosis múltiple.

IP: Red Española de Esclerosis Múltiple (perteneciente a la Red CIEN C03/06): Desarrollo de marcadores biológicos y clínicos de la r
Collaborators: Carlos Nos Llopis, Jordi Rio Izquierdo, Manuel Comabella Lopez, Carmen Espejo Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 714
Reference: PI052145
Duration: 01/01/2006 - 31/12/2006

UNiC-Unitat de Neuroimmunologia Clínica

IP: UNiC-Unitat de Neuroimmunologia Clínica
Collaborators: Carlos Nos Llopis, Jordi Rio Izquierdo, Manuel Comabella Lopez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Mireia Castillo Juarez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35600
Reference: 2005SGR 01081
Duration: 01/01/2006 - 31/12/2008

Estudio predictivo de la falta de respuesta al interferon beta en pacientes con esclerosis múltiple.

IP: Jordi Rio Izquierdo
Collaborators: Carlos Nos Llopis, M Jesus Arevalo Navines
Funding agency: Instituto de Salud Carlos III
Funding: 36800
Reference: PI030173
Duration: 01/01/2003 - 28/11/2006

Related news

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Related professionals

Nuria Vidal Tarrasón

Nuria Vidal Tarrasón

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Alba Gómez Garrido

Alba Gómez Garrido

Senior researcher
Physical Medicine and Rehabilitation
Read more
Sergio Huertas Torres

Sergio Huertas Torres

Research technician
Transfusional Medicine
Read more
Ximena Garcia Torres

Ximena Garcia Torres

Administration and Management
Translational Molecular Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.